Acrux Ltd
ASX:ACR
Acrux Ltd
ASX:ACR
Price:
0.011
AUD
Market Closed
Market Cap:
AU$4.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Acrux Ltd
ASX:ACR
|
AU |
|
S.A.M Trade (Asia) Pte Ltd
OTC:SMFX
|
US |
|
C
|
Cipta Selera Murni Tbk PT
IDX:CSMI
|
ID |
|
AFC Group Holdings Ltd
NZX:AFC
|
NZ |
|
ABC India Ltd
BSE:520123
|
IN |
|
Guilin Layn Natural Ingredients Corp
SZSE:002166
|
CN |
|
P
|
Pecca Group Bhd
KLSE:PECCA
|
MY |
|
C&D Property Management Group Co Ltd
HKEX:2156
|
CN |
|
Pelayaran Tamarin Samudra Tbk PT
IDX:TAMU
|
ID |
|
freenet AG
XETRA:FNTN
|
DE |
|
ASML Holding NV
AEX:ASML
|
NL |
|
3i Group PLC
LSE:III
|
UK |
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
TW |
|
H
|
Hyperdynamics Corp
OTC:HDYNQ
|
US |
|
Cable One Inc
NYSE:CABO
|
US |
|
Daiwa Securities Group Inc
TSE:8601
|
JP |
|
GS Yuasa Corp
TSE:6674
|
JP |
|
C
|
Cyrela Brazil Realty SA Empreendimentos e Participacoes
OTC:CYRBY
|
BR |
|
Phoenix New Media Ltd
NYSE:FENG
|
CN |
|
Genesis Metals Corp
XTSX:GIS
|
CA |
|
Societe Fonciere Lyonnaise SA
PAR:FLY
|
FR |
|
ABN Amro Bank NV
OTC:AAVMY
|
NL |
|
M
|
Meridian Bioscience Inc
LSE:0K0K
|
US |
|
S
|
Sonadezi Chau Duc Shareholding Co
VN:SZC
|
VN |
Relative Value
The Relative Value of one
ACR
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.011 AUD,
Acrux Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ACR Relative Value
HIDDEN
Multiples Across Competitors
ACR Competitors Multiples
Acrux Ltd Competitors
Acrux Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Acrux Ltd
ASX:ACR
|
4.5m AUD | 0.7 | -1.9 | -3.6 | -3.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.4 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
